A groundbreaking new study suggests that obesity plays a much larger role in driving breast cancer than previously estimated. According to research published in the Journal of Epidemiology & Community Health, about 40% of hormone-positive breast cancers in postmenopausal women may be linked to excess body fat—a significantly higher percentage than earlier estimates.
Previous studies suggested that obesity was responsible for only one in 10 breast cancer cases, primarily using body mass index (BMI) as a measure. However, researchers now argue that BMI is an unreliable indicator of body fat, potentially leading to an underestimation of obesity’s true impact on breast cancer risk.
The study, led by Veronica Davila-Batista, an associate professor of epidemiology at the University of Las Palmas de Gran Canaria in Spain, challenges traditional ways of measuring obesity-related cancer risk.
Instead of relying solely on BMI, researchers compared it to a newer and more precise measure of body fat called the CUN-BAE equation. Unlike BMI, which only considers weight and height, CUN-BAE factors in age and gender, providing a better estimate of body fat percentage.
Researchers analyzed 1,022 postmenopausal women with breast cancer and compared them to 1,143 women without cancer. When using BMI as the measure, about 23% of breast cancer cases were linked to obesity. However, when using the CUN-BAE equation, that number jumped to 38%—suggesting that traditional BMI measurements may be significantly underestimating obesity’s role in breast cancer.
The impact was particularly pronounced for hormone-positive breast cancers—those fueled by estrogen and other female hormones.
The study’s results indicate a strong connection between excess body fat—more so than BMI itself—and a higher risk of postmenopausal breast cancer.
This research utilized an observational case-control design, which compared women already diagnosed with the condition (cases) to a comparable group without it (controls). Although this design cannot establish a definitive cause-and-effect relationship, the substantial statistical difference observed between the BMI and CUN-BAE findings offers robust support for the link between body fat and cancer risk.
One proposed mechanism is that fat tissue produces estrogen, a hormone that can fuel the growth of hormone-positive breast cancer cells.
According to the Cleveland Clinic, estrogen is primarily produced in the ovaries before menopause. However, after menopause, fat tissue becomes the primary source of estrogen. This means that postmenopausal women with higher levels of body fat also have higher levels of estrogen, which may increase their risk of developing hormone-driven breast cancer.
The research team emphasized the need for more accurate ways to assess body fat levels in cancer risk studies.
“The findings of this study highlight the importance of considering more accurate measures of body fat than BMI to estimate the cancer burden attributable to obesity in postmenopausal breast cancer,” the researchers concluded.
Traditional BMI estimates may underestimate the true impact of obesity on breast cancer risk, potentially leading to missed opportunities for early intervention and prevention strategies.
For women—especially those who are postmenopausal—this study serves as an important reminder that body fat levels matter, even if BMI is in the “normal” range. Here’s what this means for you:
The discovery that body fat is a more potent predictor of breast cancer than BMI marks a pivotal shift for public health. Because this observational case-control study highlights BMI’s failure to distinguish muscle from fat, validating these links across diverse populations is essential.
To provide accurate, individualized risk assessments, clinical practice should prioritize precision tools like waist circumference, DXA, or BIA.
Moving beyond the scale toward direct adiposity measures will foster more targeted and effective strategies against postmenopausal breast cancer.
This study presents compelling new evidence that obesity plays a more powerful role in breast cancer risk than previously recognized. By using better measures of body fat, researchers can provide more accurate estimates of obesity-related cancer risk—helping women make informed decisions about their health. For postmenopausal women, understanding the connection between body fat and breast cancer is crucial. Whether through lifestyle changes, regular screenings, or more precise body composition assessments, taking proactive steps can help reduce the risk of hormone-positive breast cancer and improve long-term health outcomes.
By subscribing, you consent to receive emails from BlackDoctor.com. You may unsubscribe at any time. Privacy Policy & Terms of Service.
